{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:20:29Z","timestamp":1793431229057,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41375-019-0496-7","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T13:07:30Z","timestamp":1561554450000},"page":"2241-2253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":256,"title":["Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study"],"prefix":"10.1038","volume":"33","author":[{"name":"on behalf of the EuroClonality-NGS working group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Br\u00fcggemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kotrov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Knecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Bartram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Boudjogrha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojtech","family":"Bystry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-8422","authenticated-orcid":false,"given":"Grazia","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Fro\u0148kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2741-8047","authenticated-orcid":false,"given":"Mathieu","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Grioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Krejci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-3531","authenticated-orcid":false,"given":"John","family":"Moppett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Reigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Salson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Scheijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Songia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Svaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J. M.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Villarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Wakeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Davi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Garc\u00eda-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J. T. A.","family":"Groenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Pott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Trka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Darzentas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton W.","family":"Langerak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"496_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/302575a0","volume":"302","author":"S Tonegawa","year":"1983","unstructured":"Tonegawa S. Somatic generation of antibody diversity. Nature. 1983;302:575\u201381.","journal-title":"Nature"},{"key":"496_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/334395a0","volume":"334","author":"MM Davis","year":"1988","unstructured":"Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334:395\u2013402.","journal-title":"Nature"},{"key":"496_CR3","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nri1225","volume":"3","author":"MS Schlissel","year":"2003","unstructured":"Schlissel MS. Regulating antigen-receptor gene assembly. Nat Rev Immunol. 2003;3:890\u20139.","journal-title":"Nat Rev Immunol"},{"key":"496_CR4","unstructured":"Lefranc M-P, Lefranc G. The T cell receptor factsbook. Academic Press; 2001. https:\/\/www.sciencedirect.com\/science\/book\/9780124413528 . Accessed 22 Mar 2018."},{"key":"496_CR5","doi-asserted-by":"crossref","unstructured":"Lefranc M-P, Lefranc G The immunoglobulin factsbook. Academic Press; 2001.","DOI":"10.1016\/B978-012441352-8\/50008-4"},{"key":"496_CR6","doi-asserted-by":"crossref","unstructured":"Monroe JG, Dorshkind K. Fate decisions regulating bone marrow and peripheral B lymphocyte development. Adv Immunol. 2007;95:1\u201350.","DOI":"10.1016\/S0065-2776(07)95001-4"},{"key":"496_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ni.1794","volume":"11","author":"H von Boehmer","year":"2010","unstructured":"von Boehmer H, Melchers F. Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol. 2010;11:14\u201320.","journal-title":"Nat Immunol"},{"key":"496_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.leu.2404479","volume":"21","author":"PAS Evans","year":"2007","unstructured":"Evans PAS, Pott C, Groenen PJTA, Salles G, Davi F, Berger F, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:207\u201314.","journal-title":"Leukemia"},{"key":"496_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/sj.leu.2404481","volume":"21","author":"M Br\u00fcggemann","year":"2007","unstructured":"Br\u00fcggemann M, White H, Gaulard P, Garcia-Sanz R, Gameiro P, Oeschger S, et al. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia. 2007;21:215\u201321.","journal-title":"Leukemia"},{"key":"496_CR10","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1038\/leu.2012.246","volume":"26","author":"AW Langerak","year":"2012","unstructured":"Langerak AW, Groenen PJTA, Br\u00fcggemann M, Beldjord K, Bellan C, Bonello L, et al. EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations. Leukemia. 2012;26:2159\u201371.","journal-title":"Leukemia"},{"key":"496_CR11","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM van Dongen","year":"2003","unstructured":"van Dongen JJM, Langerak AW, Br\u00fcggemann M, Evans PAS, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257\u2013317.","journal-title":"Leukemia"},{"key":"496_CR12","doi-asserted-by":"publisher","first-page":"12ra23","DOI":"10.1126\/scitranslmed.3000540","volume":"1","author":"SD Boyd","year":"2009","unstructured":"Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci Transl Med. 2009;1:12ra23.","journal-title":"Sci Transl Med"},{"key":"496_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nbt.2492","volume":"31","author":"BJ DeKosky","year":"2013","unstructured":"DeKosky BJ, Ippolito GC, Deschner RP, Lavinder JJ, Wine Y, Rawlings BM, et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat Biotechnol. 2013;31:166\u20139.","journal-title":"Nat Biotechnol"},{"key":"496_CR14","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.3324\/haematol.2017.174987","volume":"103","author":"J Bartram","year":"2018","unstructured":"Bartram J, Goulden N, Wright G, Adams S, Brooks T, Edwards D, et al. High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments. Haematologica. 2018;103:e110\u2013e114.","journal-title":"Haematologica"},{"key":"496_CR15","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1182\/blood-2012-07-444042","volume":"120","author":"M Faham","year":"2012","unstructured":"Faham M, Zheng J, Moorhead M, Carlton VE, Stow P, Coustan-Smith E, et al. Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2012;120:5173\u201380.","journal-title":"Blood"},{"key":"496_CR16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/leu.2013.375","volume":"28","author":"M Ladetto","year":"2014","unstructured":"Ladetto M, Bruggemann M, Monitillo L, Ferrero S, Pepin F, Drandi D, et al. Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia. 2014;28:1299\u2013307.","journal-title":"Leukemia"},{"key":"496_CR17","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1182\/blood-2014-12-615757","volume":"125","author":"MA Pulsipher","year":"2015","unstructured":"Pulsipher MA, Carlson C, Langholz B, Wall DA, Schultz KR, Bunin N, et al. IgH-V(D)J NGS-MRD measurement pre- and early post- allo-transplant defines very low and very high risk ALL patients. Blood. 2015;125:3501\u20138.","journal-title":"Blood"},{"key":"496_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1182\/blood-2015-07-655159","volume":"126","author":"M Kotrova","year":"2015","unstructured":"Kotrova M, Muzikova K, Mejstrikova E, Novakova M, Bakardjieva-Mihaylova V, Fiser K, et al. The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL. Blood. 2015;126:1045\u20137.","journal-title":"Blood"},{"key":"496_CR19","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.4049\/jimmunol.1602050","volume":"198","author":"AW Langerak","year":"2017","unstructured":"Langerak AW, Br\u00fcggemann M, Davi F, Darzentas N, Gonzalez D, Cazzaniga G, et al. High throughput immunogenetics for clinical and research applications in immunohematology: potential and challenges. J Immunol. 2017;198:3765\u201374.","journal-title":"J Immunol"},{"key":"496_CR20","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/bmt.2017.16","volume":"52","author":"M Kotrova","year":"2017","unstructured":"Kotrova M, van der Velden VHJ, van Dongen JJM, Formankova R, Sedlacek P, Br\u00fcggemann M, et al. Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL. Bone Marrow Transpl. 2017;52:962\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"496_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s40291-017-0277-9","volume":"21","author":"Michaela Kotrova","year":"2017","unstructured":"Kotrova M, Trka J, Kneba M, Br\u00fcggemann M. Is next-generation sequencing the way to go for residual disease monitoring in acute lymphoblastic leukemia? Mol Diagn Ther. 2017. https:\/\/doi.org\/10.1007\/s40291-017-0277-9 .","journal-title":"Molecular Diagnosis & Therapy"},{"key":"496_CR22","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1101\/gr.092924.109","volume":"19","author":"JD Freeman","year":"2009","unstructured":"Freeman JD, Warren RL, Webb JR, Nelson BH, Holt RA. Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res. 2009;19:1817\u201324.","journal-title":"Genome Res"},{"key":"496_CR23","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1182\/blood-2012-05-429811","volume":"120","author":"C Gawad","year":"2012","unstructured":"Gawad C, Pepin F, Carlton VEH, Klinger M, Logan AC, Miklos DB, et al. Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood. 2012;120:4407\u201317.","journal-title":"Blood"},{"key":"496_CR24","doi-asserted-by":"publisher","first-page":"21194","DOI":"10.1073\/pnas.1118357109","volume":"108","author":"AC Logan","year":"2011","unstructured":"Logan AC, Gao H, Wang C, Sahaf B, Jones CD, Marshall EL, et al. High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc Natl Acad Sci USA. 2011;108:21194\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"496_CR25","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/leu.2013.52","volume":"27","author":"AC Logan","year":"2013","unstructured":"Logan AC, Zhang B, Narasimhan B, Carlton V, Zheng J, Moorhead M, et al. Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. Leukemia. 2013;27:1659\u201365.","journal-title":"Leukemia"},{"key":"496_CR26","doi-asserted-by":"publisher","first-page":"47ra64","DOI":"10.1126\/scitranslmed.3001442","volume":"2","author":"HS Robins","year":"2010","unstructured":"Robins HS, Srivastava SK, Campregher PV, Turtle CJ, Andriesen J, Riddell SR, et al. Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci Transl Med. 2010;2:47ra64\u201347ra64.","journal-title":"Sci Transl Med"},{"key":"496_CR27","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1073\/pnas.0913939107","volume":"107","author":"C Wang","year":"2010","unstructured":"Wang C, Sanders CM, Yang Q, Schroeder HW, Wang E, Babrzadeh F, et al. High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proc Natl Acad Sci. 2010;107:1518\u201323.","journal-title":"Proc Natl Acad Sci"},{"key":"496_CR28","doi-asserted-by":"publisher","first-page":"134ra63","DOI":"10.1126\/scitranslmed.3003656","volume":"4","author":"D Wu","year":"2012","unstructured":"Wu D, Sherwood A, Fromm JR, Winter SS, Dunsmore KP, Loh ML, et al. High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia. Sci Transl Med. 2012;4:134ra63\u2013134ra63.","journal-title":"Sci Transl Med"},{"key":"496_CR29","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1182\/blood-2010-03-275859","volume":"116","author":"Y-C Wu","year":"2010","unstructured":"Wu Y-C, Kipling D, Leong HS, Martin V, Ademokun AA, Dunn-Walters DK. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood. 2010;116:1070\u20138.","journal-title":"Blood"},{"key":"496_CR30","unstructured":"Knecht H, Reigl T, Kotrov\u00e1 M, Appelt F, Stewart P, Bystry V, et al. Quality control and quantification in IG\/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS. Leukemia; revision. [Epub ahead of print]"},{"key":"496_CR31","unstructured":"Scheijen B, Meijers R, Rijntjes J, van der Klift M, M\u00f6bs M, Steinhilber J, et al. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS. Leukemia; revision. [Epub ahead of print]"},{"key":"496_CR32","doi-asserted-by":"publisher","first-page":"btw634","DOI":"10.1093\/bioinformatics\/btw634","volume":"33","author":"V Bystry","year":"2016","unstructured":"Bystry V, Reigl T, Krejci A, Demko M, Hanakova B, Grioni A, et al. ARResT\/Interrogate: an interactive immunoprofiler for IG\/TR NGS data. Bioinformatics. 2016;33:btw634.","journal-title":"Bioinformatics"},{"key":"496_CR33","first-page":"365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000;132:365\u201386.","journal-title":"Methods Mol Biol"},{"key":"496_CR34","doi-asserted-by":"publisher","first-page":"W205","DOI":"10.1093\/nar\/gks552","volume":"40","author":"W Qu","year":"2012","unstructured":"Qu W, Zhou Y, Zhang Y, Lu Y, Wang X, Zhao D, et al. MFEprimer-2.0: a fast thermodynamics-based program for checking PCR primer specificity. Nucleic Acids Res. 2012;40:W205\u20138.","journal-title":"Nucleic Acids Res"},{"key":"496_CR35","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.leu.2404586","volume":"21","author":"VHJ van der Velden","year":"2007","unstructured":"van der Velden VHJ, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer ER, et al. Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia. 2007;21:604\u201311.","journal-title":"Leukemia"},{"key":"496_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.leu.2401245","volume":"13","author":"MJ Pongers-Willemse","year":"1999","unstructured":"Pongers-Willemse MJ, Seriu T, Stolz F, D\u2019Aniello E, Gameiro P, Pisa P, et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION. Leukemia. 1999;13:110\u20138.","journal-title":"Leukemia"},{"key":"496_CR37","doi-asserted-by":"publisher","first-page":"e0166126","DOI":"10.1371\/journal.pone.0166126","volume":"11","author":"M Duez","year":"2016","unstructured":"Duez M, Giraud M, Herbert R, Rocher T, Salson M, Thonier F, et al. Vidjil: a web platform for analysis of high-throughput repertoire sequencing. PLoS ONE. 2016;11:e0166126.","journal-title":"PLoS One"},{"key":"496_CR38","first-page":"695","volume":"2011","author":"V Giudicelli","year":"2011","unstructured":"Giudicelli V, Brochet X, Lefranc M-P. IMGT\/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell. Recept (TR) Nucleotide Seq Cold Spring Harb Protoc. 2011;2011:695\u2013715.","journal-title":"Recept (TR) Nucleotide Seq Cold Spring Harb Protoc"},{"key":"496_CR39","doi-asserted-by":"publisher","first-page":"D256","DOI":"10.1093\/nar\/gki010","volume":"33","author":"V Giudicelli","year":"2005","unstructured":"Giudicelli V, Chaume D, Lefranc MP. IMGT\/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res. 2005;33:D256\u201361.","journal-title":"Nucleic Acids Res"},{"key":"496_CR40","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1182\/blood-2003-08-2952","volume":"103","author":"T Szczepanski","year":"2004","unstructured":"Szczepanski T, Van Der Velden VHJ, Hoogeveen PG, De Bie M, Jacobs CH, Van Wering ER, et al. Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells. Blood. 2004;103:3798\u2013804.","journal-title":"Blood"},{"key":"496_CR41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0923-2494(90)90058-7","volume":"141","author":"MP Lefranc","year":"1990","unstructured":"Lefranc MP, Rabbitts TH. Genetic organization of the human T-cell receptor gamma and delta loci. Res Immunol. 1990;141:565\u201377.","journal-title":"Res Immunol"},{"key":"496_CR42","unstructured":"Dongen J van, Szczepanski T, Adriaansen H. Immunobiology of leukemia. 7th edn. WB Saudners Company: Philadelphia; 2002."},{"key":"496_CR43","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJ van Dongen","year":"1998","unstructured":"van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet. 1998;352:1731\u20138.","journal-title":"Lancet"},{"key":"496_CR44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood.V81.3.775.775","volume":"81","author":"GR Kitchingman","year":"1993","unstructured":"Kitchingman GR. Immunoglobulin heavy chain gene VH-D junctional diversity at diagnosis in patients with acute lymphoblastic leukemia. Blood. 1993;81:775\u201382.","journal-title":"Blood"},{"key":"496_CR45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood.V82.2.581.581","volume":"82","author":"EJ Steenbergen","year":"1993","unstructured":"Steenbergen EJ, Verhagen OJ, van Leeuwen EF, von dem Borne AE, van der Schoot CE. Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia. Blood. 1993;82:581\u20139.","journal-title":"Blood"},{"key":"496_CR46","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1182\/blood.V99.7.2315","volume":"99","author":"T Szczepa\u0144ski","year":"2002","unstructured":"Szczepa\u0144ski T, Willemse MJ, Brinkhof B, van Wering ER, van der Burg M, van Dongen JJM. Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease. Blood. 2002;99:2315\u201323.","journal-title":"Blood"},{"key":"496_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/sj.leu.2401970","volume":"15","author":"V de Haas","year":"2001","unstructured":"de Haas V, Verhagen OJ, von dem Borne AE, Kroes W, van den Berg H, van der Schoot CE. Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy. Leukemia. 2001;15:134\u201340.","journal-title":"Leukemia"},{"key":"496_CR48","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/sj.leu.2403008","volume":"17","author":"G Germano","year":"2003","unstructured":"Germano G, del Giudice L, Palatron S, Giarin E, Cazzaniga G, Biondi A, et al. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring. Leukemia. 2003;17:1573\u201382.","journal-title":"Leukemia"},{"key":"496_CR49","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3324\/haematol.2017.171454","volume":"102","author":"PMJ Theunissen","year":"2017","unstructured":"Theunissen PMJ, van Zessen D, Stubbs AP, Faham M, Zwaan CM, van Dongen JJM, et al. Antigen receptor sequencing of paired bone marrow samples shows homogeneous distribution of acute lymphoblastic leukemia subclones. Haematologica. 2017;102:1869\u201377.","journal-title":"Haematologica"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0496-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0496-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0496-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T04:02:39Z","timestamp":1721448159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0496-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1038\/s41375-019-0496-7","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The EuroClonality-NGS Working Group is an independent scientific subdivision of EuroClonality that aims at innovation, standardization and education in the field of diagnostic clonality analysis. The revenues of the previously obtained patent (PCT\/NL2003\/000690), which is collectively owned by the EuroClonality Foundation and licensed to InVivoScribe, are exclusively used for EuroClonality activities, such as for covering costs of the Working Group meetings, collective WorkPackages and the EuroClonality Educational Workshops. The EuroClonality consortium operates under an umbrella of ESLHO, which is an official EHA Scientific Working Group. MB: contract research for Affimed, Amgen, Regeneron, advisory board of Amgen, Incyte, Speaker bureau of Janssen, Pfizer, Roche. AWL: contract research for Roche-Genentech, research support from Gilead, advisory board for AbbVie, speaker for Gilead, Janssen. RG-S: research grants from Gilead, Takeda, Amgen, and the Spanish government; and reports consulting fees from Janssen, Takeda, Incyte, and BMS. KS: research support from Janssen, Abbvie, Gilead; speaker for Janssen, Abbvie, Gilead; advisory board for Janssen, Abbvie, Gilead. PG: speaker for Gilead.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}